Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
Sponsor: Verici Dx
Summary
Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstitial fibrosis / tubular atrophy by correlating peripheral blood gene expression profiles with graft injury (e.g. cellular / antibody-mediated), rejection and death censored graft loss.
Official title: Validation of Genomic Immune-phenotyping Profiles in Peripheral Blood Gene Signatures to Predict Risk of Kidney Transplant Rejection
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
550
Start Date
2021-03-21
Completion Date
2025-12-31
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Locations (13)
University of Illinois at Chicago
Chicago, Illinois, United States
Northwestern University
Evanston, Illinois, United States
University of Maryland
Baltimore, Maryland, United States
Henry Ford
Detroit, Michigan, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
University of Washington
Seattle, Washington, United States
CHU Grenoble Alpes Health Center
Grenoble, France
Bologna University
Bologna, Italy
Brescia University
Brescia, Italy
University Hospital Vall d'Hebron, Barcelona
Barcelona, Spain